DE69206721D1 - Neues Verfahren zur Herstellung von Hydrocortison sowie Zwischenprodukten dafür - Google Patents

Neues Verfahren zur Herstellung von Hydrocortison sowie Zwischenprodukten dafür

Info

Publication number
DE69206721D1
DE69206721D1 DE69206721T DE69206721T DE69206721D1 DE 69206721 D1 DE69206721 D1 DE 69206721D1 DE 69206721 T DE69206721 T DE 69206721T DE 69206721 T DE69206721 T DE 69206721T DE 69206721 D1 DE69206721 D1 DE 69206721D1
Authority
DE
Germany
Prior art keywords
hydrocortisone
production
new process
intermediates therefor
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69206721T
Other languages
English (en)
Other versions
DE69206721T2 (de
Inventor
Francis Brion
Jean Buendia
Christian Diolez
Michel Vivat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE69206721D1 publication Critical patent/DE69206721D1/de
Application granted granted Critical
Publication of DE69206721T2 publication Critical patent/DE69206721T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007Cyclic thioketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69206721T 1991-09-06 1992-09-03 Neues Verfahren zur Herstellung von Hydrocortison sowie Zwischenprodukten dafür Expired - Lifetime DE69206721T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9111052A FR2681069B1 (fr) 1991-09-06 1991-09-06 Nouveau procede de preparation de l'hydrocortisone et nouveaux intermediaires.

Publications (2)

Publication Number Publication Date
DE69206721D1 true DE69206721D1 (de) 1996-01-25
DE69206721T2 DE69206721T2 (de) 1996-05-23

Family

ID=9416716

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69206721T Expired - Lifetime DE69206721T2 (de) 1991-09-06 1992-09-03 Neues Verfahren zur Herstellung von Hydrocortison sowie Zwischenprodukten dafür

Country Status (20)

Country Link
US (4) US5260463A (de)
EP (1) EP0531212B1 (de)
JP (1) JP3466645B2 (de)
KR (1) KR100220542B1 (de)
CN (1) CN1035947C (de)
AT (1) ATE131488T1 (de)
AU (1) AU653841B2 (de)
CA (1) CA2077625C (de)
DE (1) DE69206721T2 (de)
DK (1) DK0531212T3 (de)
ES (1) ES2089449T3 (de)
FR (1) FR2681069B1 (de)
GR (1) GR3018402T3 (de)
HU (1) HU212666B (de)
MX (1) MX9205063A (de)
PL (5) PL172040B1 (de)
RU (1) RU2060257C1 (de)
TW (1) TW269693B (de)
UA (1) UA35556C2 (de)
ZA (1) ZA925516B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683530B1 (fr) * 1991-11-08 1994-01-21 Roussel Uclaf Nouveau procede de preparation de derives 20-oxo 17 alpha, 21-dihydroxyles du pregnane et nouveaux intermediaires.
FR2691968B1 (fr) * 1992-06-04 1994-07-29 Roussel Uclaf Nouveau procede de preparation d'un derive sterouide 11-ceto.
FR2719588B1 (fr) * 1994-05-03 1996-06-07 Roussel Uclaf Nouveau procédé de préparation de la substance "S" et nouveaux intermédiaires.
FR2721927B1 (fr) * 1994-07-01 1996-08-09 Roussel Uclaf Nouveau procede de preparation de derives steroides 20-oxo 17 alpha, 21-dihydroxyles et nouveaux intermediaires
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
US6348324B1 (en) 1999-01-21 2002-02-19 Hypoguard America Limited Composition and device for detecting leukocytes in urine
US6528652B1 (en) 1999-01-21 2003-03-04 Chronimed Composition and device for detecting leukocytes in urine
US8990064B2 (en) * 2009-07-28 2015-03-24 Language Weaver, Inc. Translating documents based on content

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744110A (en) * 1954-04-22 1956-05-01 Searle & Co 3-ethylene mercaptole derivatives of progesterone
GB1089788A (en) * 1965-07-07 1967-11-08 Parke Davis & Co Process for the production of steroidal lactone compounds and intermediates thereof
NL7607283A (nl) * 1975-07-23 1977-01-25 Merck & Co Inc Werkwijze voor het bereiden van nieuwe pregnaansteroiden.
FR2344286A1 (fr) * 1976-03-16 1977-10-14 Roussel Uclaf Nouveaux derives 17-spirosultines, les g-hydroxy acides correspondants, leur procede de preparation et leur application comme medicament
US5182381A (en) * 1982-03-01 1993-01-26 Roussel Ulcaf Intermediates for 3-keto-19-nor-Δ4,9 -steroids
EP0123734A1 (de) * 1983-04-29 1984-11-07 Gist-Brocades N.V. 17-(Isocyano-sulfonylmethylen)-Steroide, 17-(Formamido-sulfonylmethylen)-Steroide und ihre Herstellung
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
PT90227B (pt) * 1988-04-08 1994-06-30 Roussel Uclaf Processo para a preparacao de esteroides de 9 alfa-hidroxi-17-metileno

Also Published As

Publication number Publication date
EP0531212A2 (de) 1993-03-10
ZA925516B (en) 1993-07-22
US5260463A (en) 1993-11-09
US5401840A (en) 1995-03-28
JP3466645B2 (ja) 2003-11-17
CN1070196A (zh) 1993-03-24
US5502182A (en) 1996-03-26
MX9205063A (es) 1993-05-01
KR100220542B1 (ko) 1999-10-01
PL172040B1 (pl) 1997-07-31
CA2077625A1 (fr) 1993-03-07
RU2060257C1 (ru) 1996-05-20
EP0531212B1 (de) 1995-12-13
FR2681069A1 (fr) 1993-03-12
PL172822B1 (en) 1997-11-28
AU2057092A (en) 1993-03-11
AU653841B2 (en) 1994-10-13
CN1035947C (zh) 1997-09-24
JPH05194581A (ja) 1993-08-03
UA35556C2 (uk) 2001-04-16
TW269693B (de) 1996-02-01
CA2077625C (fr) 2003-10-28
HUT62598A (en) 1993-05-28
HU212666B (en) 1996-09-30
HU9202851D0 (en) 1992-11-30
DK0531212T3 (da) 1997-03-03
US5556962A (en) 1996-09-17
GR3018402T3 (en) 1996-03-31
PL295836A1 (en) 1993-05-17
ES2089449T3 (es) 1996-10-01
PL172809B1 (pl) 1997-11-28
PL173272B1 (pl) 1998-02-27
DE69206721T2 (de) 1996-05-23
ATE131488T1 (de) 1995-12-15
EP0531212A3 (en) 1993-05-26
PL173589B1 (pl) 1998-03-31
KR930006048A (ko) 1993-04-20
FR2681069B1 (fr) 1995-04-28

Similar Documents

Publication Publication Date Title
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
DE69526436T2 (de) Verfahren zur herstellung von avermectin/zein-zusammensetzungen
DE69206721T2 (de) Neues Verfahren zur Herstellung von Hydrocortison sowie Zwischenprodukten dafür
ATE13666T1 (de) Verfahren zur herstellung von cyclohexenderivaten.
ATE117994T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethylpyridin.
DE69513847T2 (de) Verfahren zur herstellung von substituierten 3-aminobenzonitrilen
ATE277915T1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
DE69400343T2 (de) Neues Verfahren zur Herstellung von 6alpha, 9alphadifluoro-Sterioden und Zwischenprodukte davon
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
ATE55382T1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten sowie von d-alphatocopherol.
DE69109207D1 (de) Verfahren zur Herstellung von kleinen röhrenförmigen Lampen.
ATE239695T1 (de) Stereoselektive verfahren zur herstellung von gabapentinanalogen
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ATE134627T1 (de) Verfahren zur herstellung von 1r, cis 2,2,- dimethyl-3-formyl-cyclopropan-1-carbonsäurelact n und halogenierten zwischenverbindungen
DE3762845D1 (de) Verfahren zur herstellung von optisch aktiven hydrochinonderivaten, sowie von d-alpha-tocopherol.
ATE146785T1 (de) Verfahren zur herstellung von diltiazem
ATE282026T1 (de) Verfahren zur herstellung von halo-4-phenoxy- chinolinen
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
DE69608512T2 (de) Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten
DE3584893D1 (de) Verfahren zur herstellung von 4,6-diamino-2-vinyl-s-triazin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

R071 Expiry of right

Ref document number: 531212

Country of ref document: EP